Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Cognitive-behavioral therapy is the best treatment for hair-pulling disorder, and combining it with other therapies could improve results.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

DNA variants can predict male pattern baldness, with higher risk scores increasing baldness likelihood.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

The study concluded that yellow dots are a common and useful sign for diagnosing alopecia areata in dark-skinned individuals and may indicate the severity of the condition.

USPlus PRO saw palmetto extract improves urinary symptoms and is safe for men.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.

miR-155-5p can help diagnose and track alopecia areata severity.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Certain gene variants can influence acne risk and severity.

Balancing testosterone may reduce COVID-19 severity.

Increased HIF-1α is linked to the inflammation and severity of hidradenitis suppurativa, suggesting treatments that lower HIF-1α could help.

Systemic retinoids do not increase COVID-19 risk or severity.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Portuguese WAA-QoL questionnaire validated; FPHL severity, schooling, and phototypes affect patients' quality of life.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Deuruxolitinib significantly helps regrow scalp hair in adults with moderate to severe alopecia areata.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.